NZ290974A - Treatment of opportunistic infections with axaspirane compounds - Google Patents
Treatment of opportunistic infections with axaspirane compoundsInfo
- Publication number
- NZ290974A NZ290974A NZ290974A NZ29097495A NZ290974A NZ 290974 A NZ290974 A NZ 290974A NZ 290974 A NZ290974 A NZ 290974A NZ 29097495 A NZ29097495 A NZ 29097495A NZ 290974 A NZ290974 A NZ 290974A
- Authority
- NZ
- New Zealand
- Prior art keywords
- axaspirane
- compounds
- treatment
- opportunistic infections
- opportunistic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9414902A GB9414902D0 (en) | 1994-07-23 | 1994-07-23 | Methods |
| PCT/US1995/008915 WO1996003126A1 (en) | 1994-07-23 | 1995-07-14 | Method of treating opportunistic infections with azaspiranes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ290974A true NZ290974A (en) | 1999-08-30 |
Family
ID=10758802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ290974A NZ290974A (en) | 1994-07-23 | 1995-07-14 | Treatment of opportunistic infections with axaspirane compounds |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0804201A4 (en) |
| JP (1) | JPH10503202A (en) |
| KR (1) | KR970704446A (en) |
| CN (1) | CN1157564A (en) |
| AU (1) | AU684384B2 (en) |
| BR (1) | BR9508332A (en) |
| CA (1) | CA2195778A1 (en) |
| CZ (1) | CZ286482B6 (en) |
| GB (1) | GB9414902D0 (en) |
| HU (1) | HUT77379A (en) |
| MX (1) | MX9700626A (en) |
| NO (1) | NO310096B1 (en) |
| NZ (1) | NZ290974A (en) |
| WO (1) | WO1996003126A1 (en) |
| ZA (1) | ZA956098B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9601909A (en) * | 1995-07-13 | 1999-10-13 | Smithkline Beecham Corp | N, n-diethyl-8,8-dipropyl-2-azaspiro (4,5) decane-2-propan amine dimaleate |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4963557A (en) * | 1987-09-28 | 1990-10-16 | Smithkline Beecham Corporation | Immunomodulatory azaspiranes |
| ZA921120B (en) * | 1991-02-19 | 1993-01-27 | Smithkline Beecham Corp | Cytokine inhibitors |
| PT100566B (en) * | 1991-06-07 | 1999-06-30 | Smithkline Beecham Corp | IMMUNOMODULATOR AZASPIRANES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION AND USE |
-
1994
- 1994-07-23 GB GB9414902A patent/GB9414902D0/en active Pending
-
1995
- 1995-07-14 CA CA002195778A patent/CA2195778A1/en not_active Abandoned
- 1995-07-14 KR KR1019970700433A patent/KR970704446A/en not_active Application Discontinuation
- 1995-07-14 AU AU31909/95A patent/AU684384B2/en not_active Ceased
- 1995-07-14 WO PCT/US1995/008915 patent/WO1996003126A1/en not_active Application Discontinuation
- 1995-07-14 NZ NZ290974A patent/NZ290974A/en unknown
- 1995-07-14 MX MX9700626A patent/MX9700626A/en not_active IP Right Cessation
- 1995-07-14 BR BR9508332A patent/BR9508332A/en not_active Application Discontinuation
- 1995-07-14 EP EP95928072A patent/EP0804201A4/en not_active Withdrawn
- 1995-07-14 HU HU9700201A patent/HUT77379A/en unknown
- 1995-07-14 CN CN95195052A patent/CN1157564A/en active Pending
- 1995-07-14 CZ CZ1997209A patent/CZ286482B6/en not_active IP Right Cessation
- 1995-07-14 JP JP8505798A patent/JPH10503202A/en active Pending
- 1995-07-21 ZA ZA956098A patent/ZA956098B/en unknown
-
1997
- 1997-01-22 NO NO19970284A patent/NO310096B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996003126A1 (en) | 1996-02-08 |
| HUT77379A (en) | 1998-04-28 |
| NO310096B1 (en) | 2001-05-21 |
| HU9700201D0 (en) | 1997-04-28 |
| GB9414902D0 (en) | 1994-09-14 |
| EP0804201A4 (en) | 2000-04-26 |
| BR9508332A (en) | 1997-11-04 |
| ZA956098B (en) | 1996-05-23 |
| NO970284L (en) | 1997-03-19 |
| KR970704446A (en) | 1997-09-06 |
| CA2195778A1 (en) | 1996-02-08 |
| MX9700626A (en) | 1997-05-31 |
| JPH10503202A (en) | 1998-03-24 |
| NO970284D0 (en) | 1997-01-22 |
| AU684384B2 (en) | 1997-12-11 |
| EP0804201A1 (en) | 1997-11-05 |
| CZ286482B6 (en) | 2000-04-12 |
| CZ20997A3 (en) | 1997-10-15 |
| CN1157564A (en) | 1997-08-20 |
| AU3190995A (en) | 1996-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9411080D0 (en) | Treatment | |
| GB2287879B (en) | Baths | |
| IL113248A0 (en) | Use of alpha - 1c specific compounds | |
| GB9324773D0 (en) | Treatment of cellulose | |
| GB9603747D0 (en) | Treatment of liquors | |
| GB9418762D0 (en) | Use of substituted cyclopentane-DI-and-triones | |
| HU9700071D0 (en) | Use of muramilpeptides | |
| GB9410512D0 (en) | Novel treatment | |
| ZA952839B (en) | Treatment of H pylori infections | |
| EP0755255A4 (en) | Treatment of toxoplasmosis | |
| GB9419692D0 (en) | Treatment of herpes infections | |
| GB9411635D0 (en) | Novel treatment | |
| GB9419571D0 (en) | Treatment of oral infections | |
| PL317876A1 (en) | Combined treatment of hiv infections | |
| NZ290974A (en) | Treatment of opportunistic infections with axaspirane compounds | |
| GB9415901D0 (en) | Novel compounds and treatment | |
| GB9416410D0 (en) | Effluent treatment | |
| GB9415900D0 (en) | Novel compounds and treatment | |
| GB9420080D0 (en) | The treatment of liquids | |
| GB9425796D0 (en) | The preparation of halogenated compounds | |
| GB2301353B (en) | Treatment of undesirable halogenated organic compounds | |
| ZA952405B (en) | Solutions of dirithromycin | |
| GB2285936B (en) | Treatment of fluids | |
| GB9424471D0 (en) | Treatment of emesis | |
| GB9415920D0 (en) | Novel compounds and treatment |